浙江医药(600216) - 2024 Q1 - 季度财报

| --- | --- | --- | |-------------------------------------------|-------------------|-------------------| | 流动负债合计 | 2,385,152,071.48 | 2,478,442,290.22 | | 非流动负债： | | | | 保险合同准备金 | | | | 长期借款 | 376,355,500.00 | 230,222,800.00 | | 应付债券 | | | | 其中：优先股 | | | | 永续债 | | | | 租赁负债 | 335,747.71 | 322,843.87 | | 长期应付款 | | | | 长期应付职工薪酬 | | | | 预计负债 | | | | 递延收益 | 81,470,293.11 | 84,158,052.23 | | 递延所得税负债 | | | | 其他非流动负债 | | | | 非流动负债合计 | 458,161,540.82 | 314,703,696.10 | | 负债合计 | 2,843,313,612.30 | 2,793,145,986.32 ...